GlassScriptPhysician profile
Danish Bawa
NPI 1295297042
$1,299.54
in general payments reported to CMS, 2019-2025
19 companies · $98.53 in 2025
The $98.53 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $242 · 2023: $560 · 2024: $400 · 2025: $98.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.93 |
| Education | $242.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $266.22 | 2023-2024 | Ensite, Optis |
| Sanofi-Aventis U.S. LLC | $157.26 | 2022-2023 | |
| Philips North America LLC | $143.92 | 2024 | (Bh4) Igt Devices Undivided |
| Abiomed | $119.36 | 2023 | Impella |
| Glaxosmithkline, LLC. | $113.68 | 2024 | Nucala |
| Itamar Medical INC | $85.45 | 2022 | |
| Amgen INC. | $76.85 | 2023-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $59.96 | 2024-2025 | |
| Atricure, INC. | $40.48 | 2023-2025 | Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.87 | 2023 | Lifevest |
| Novo Nordisk INC | $31.60 | 2023 | Ozempic, Rybelsus |
| Pfizer INC. | $27.17 | 2023-2024 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Lantheus Medical Imaging, INC. | $22.02 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.96 | 2023 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $21.39 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Chiesi USA, INC. | $21.36 | 2024 | Kengreal |
| Genzyme Corporation | $20.20 | 2022 | |
| Vital Connect, INC | $15.17 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danish Bawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.